Bioversys bags €17.7m financingSwiss BioVersys AG has secured a CHF19m Series B financing to push clinincal development of two antiinfectives against drug-resistant pathogens. more ➔
Sotio licences Unum Therapeutics’ CAR-T cell portfolioPPF-owned company SOTIO has acquired the rights to use the BOXR CAR-T platform and products from Cambridge-based Unum Therapeutics. more ➔
Polyphor partners with Fosun Pharma Polyphor AG has licenced its metastatic cancer drug balixafortide to Fosun Pharma Co Ltd to market the drug exclusively in China. more ➔
Engitix Ltd. lands US$500m deal with Takeda in fibrosisBritish fibrosis therapeutics start-up Engitix Ltd has entered a collaboration agreement with Takeda to develop anti-fibrotic therapies in liver diseases. more ➔
Moderna set to deliver COVID-19 jab to the EUUS experiemental mRNA vaccine maker Moderna Inc is in advanced talks with the European Commission to supply 80 million doses mRNA-1273, its candidate vs SARS-CoV-2 more ➔
Scientists map ulcerative colitisScientists from Leuven, Rotterdam and San Diego have published a sequencing-based map of ulcerative colitis paving the way to new treatments. more ➔
COVID-19: Roche and Regeneron join forcesRoche and Regeneron have signed an manufacturing and distribution agreement on Regeneron’s Phase II therapeutic antibody for the treatment of COVID-19. more ➔
Aicuris to launch AiCubator to fight AMRAntinfectives specialist AiCuris GmbH will launch the AiCubator, a new way to collaborate in anti-infectives and support novel approaches, at the 4th AMR Conference. more ➔
Cell-based vaccination vs mortality-reducing therapies Immunovative Therapies Ltd and its US subsidiary Mirror Biologics Inc. are testing a novel, T cell-based vaccination concept that might protect risk groups from new SARS-CoV-2 variants and any emerging … more ➔
AI predicts mutations underlying neurological diseases Using data from more than 20,000 patients with neurological diseases, researchers have established an algorithm that predicts whether mutations in ion channels will cause disease. more ➔
